Long-Term Visual Outcomes for a Treat and Extend Anti-Vascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration

With the advent of anti-vascular endothelial growth factor (VEGF) therapy, clinicians are now focused on various treatment strategies to better control neovascular age-related macular degeneration (NVAMD), a leading cause of irreversible blindness. Herein, we retrospectively reviewed consecutive pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mrejen, Sarah, Jung, Jesse J., Chen, Christine, Patel, Samir N., Gallego-Pinazo, Roberto, Yannuzzi, Nicolas, Xu, Luna, Marsiglia, Marcela, Boddu, Sucharita, Freund, K. Bailey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519796/
https://www.ncbi.nlm.nih.gov/pubmed/26239682
http://dx.doi.org/10.3390/jcm4071380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519796/
https://www.ncbi.nlm.nih.gov/pubmed/26239682
http://dx.doi.org/10.3390/jcm4071380

Ejemplares similares